2-(1H-1,2,4-Triazol-1-yl)ethan-1-ol, 95.0%, 100mg

Plan phase 10x/0,25 objectif corrigé à l'infini

2-{[2-formyl-4-(trifluoromethyl)phenyl](methyl)amino}acetic acid, 95%, 250mg

(E)-Hex-1-en-1-ylboronic acid, 95.0%, 5g

3-[Dimethoxy(methyl)silyl]propyl Methacrylate>98.0%(GC)25mL

2',4',6'-Triethyl-5'-(4-formylphenyl)-[1,1':3',1''-terphenyl]-4,4''-dicarbaldehyde, 98%, 1g

(2S,4S)-1-tert-Butyl 2-methyl 4-aminopyrrolidine-1,2-dicarboxylate, 95.0%, 250mg

2,2-Difluoropropionic acid, 98.0%, 25g

Acetyl-L-methionine methyl ester, 95.0%, 1g

2'-(4-Fluorobenzyloxy)acetophenone, 99.0%, 1g

BENZYL 1-OXO-2,5-DIAZASPIRO[3.4]OCTANE-5-CARBOXYLATE, 95.0%, 2g

3-Hydroxy-1H-pyrazole-4-carboxylic acid ethyl ester, 95.0%, 25g

1-(4-Aminobenzyl)-1,2,4-triazol, 97.0%, 250mg